We are live on ! Find out more
MBOT icon

Microbot Medical
MBOT

26 hedge funds and large institutions have $2.1M invested in Microbot Medical in 2017 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 3

33% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 3

8% more funds holding

Funds holding: 24 → 26 (+2)

0.04% less ownership

Funds ownership: 0.39% → 0.34% (-0.04%)

10% less capital invested

Capital invested by funds: $2.33M → $2.1M (-$225K)

Holders
26
Holders Change
+2
Holders Change %
+8.33%
% of All Funds
0.65%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
4
Reduced
3
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$171K
2
Squarepoint
Squarepoint
New York
+$45.7K
3
Millennium Management
Millennium Management
New York
+$20.8K
4
Bank of New York Mellon
Bank of New York Mellon
New York
+$15.5K
5
GC
Guggenheim Capital
Illinois
+$15.3K

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$39.9K
2
Bank of Montreal
Bank of Montreal
Ontario, Canada
-$18.8K
3
Morgan Stanley
Morgan Stanley
New York
-$7.58K
4
Creative Planning
Creative Planning
Kansas
-$6K
5
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance)
Ontario, Canada
-$229
Name Holding Trade Value Shares
Change 		Change in
Stake
SM
1
Sabby Management
Florida
$1.46M -$39.9K -2,263 -3%
Vanguard Group
2
Vanguard Group
Pennsylvania
$358K +$171K +9,719 +91%
BlackRock
3
BlackRock
New York
$63K – – –
Geode Capital Management
4
Geode Capital Management
Massachusetts
$58K – – –
Squarepoint
5
Squarepoint
New York
$46K +$45.7K +2,593 New
TSS
6
Two Sigma Securities
New York
$30K +$1.53K +87 +5%
Millennium Management
7
Millennium Management
New York
$21K +$20.8K +1,178 New
Northern Trust
8
Northern Trust
Illinois
$17K – – –
GC
9
Guggenheim Capital
Illinois
$15K +$15.3K +867 New
Bank of New York Mellon
10
Bank of New York Mellon
New York
$15K +$15.5K +878 New
Deutsche Bank
11
Deutsche Bank
Germany
$11K +$8.5K +482 +323%
Wells Fargo
12
Wells Fargo
California
$4K +$3.53K +200 New
Morgan Stanley
13
Morgan Stanley
New York
$1K -$7.58K -430 -87%
FDCDDQ
14
Federation des caisses Desjardins du Quebec
Quebec, Canada
$64 – – –
RE
15
RBC Europe
United Kingdom
$4 – – –
Bank of Montreal
16
Bank of Montreal
Ontario, Canada
– -$18.8K -1,067 -100%
Creative Planning
17
Creative Planning
Kansas
– -$6K -284 Closed
Manulife (Manufacturers Life Insurance)
18
Manulife (Manufacturers Life Insurance)
Ontario, Canada
– -$229 -13 Closed
PFO
19
Pathstone Family Office
New Jersey
– +$88 +5 +25%
IA
20
IFP Advisors
Florida
– +$247 +14 New

MBOT Hedge Fund Activity: Q3 2017 in Review

26 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Microbot Medical (MBOT) for Q3 2017, worth a combined $2.1M — down 9.7% from $2.33M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new MBOT positions and 3 closed out — a net gain of 3 holders — while 4 added to existing stakes and 3 trimmed.

The largest buyer was Vanguard Group, adding an estimated $171K. The largest seller was Sabby Management, cutting an estimated $39.9K.

  • 26 institutional investors held Microbot Medical (MBOT) as of Q3 2017, up from 24 in Q2 2017.
  • Funds reported $2.1M of Microbot Medical stock for Q3 2017, down 9.7% quarter-over-quarter.
  • 6 funds opened new Microbot Medical positions in Q3 2017 and 3 closed out, a net change of +3 holders.
  • The largest Microbot Medical buyer in Q3 2017 was Vanguard Group, an estimated $171K added.
  • The largest Microbot Medical seller in Q3 2017 was Sabby Management, an estimated $39.9K sold.

Based on aggregated 13F filings for Q3 2017.